Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (ISRG) Stock Overview
Explore Intuitive Surgical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
ISRG Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Intuitive Surgical, Inc. (ISRG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $762.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 77.03 and a market capitalization of 191.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Analyst Recommendations
Price Targets
Company Profile
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Dr. Gary S. Guthart Ph.D.
15,638
1020 Kifer Road, Sunnyvale, CA
2000